“Using Panitumumab with metronomic Capecitabine ... with only 8% of patients experiencing severe side effects such as skin rash or diarrhea, which were managed with standard treatments.

Notably, Erbitux [cetuximab], Vectibix [panitumumab] are notorious for causing rashes, but we’ve not seen as much of a rash with these drugs when we combine them with Krazati [adagrasib] in the study, ...